-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – GUR-701 in Androgenic Alopecia
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - GUR-701 in Androgenic Alopecia report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. GUR-701 in Androgenic Alopecia Drug Details: GUR-701 is under development for the...
-
Product Insights
Systemic Sclerosis (Scleroderma) – Drugs In Development, 2023
Global Markets Direct’s, ‘Systemic Sclerosis (Scleroderma) - Drugs In Development, 2023’, provides an overview of the Systemic Sclerosis (Scleroderma) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Systemic Sclerosis (Scleroderma), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the...
-
Product Insights
Ripa d’Api Solar PV Park
Ripa d~Api Solar PV Park is a solar PV project located in Basilicata, Italy. The project is owned and being developed by Renantis. The project is at the permitting stage. Empower your strategies with our Ripa d~Api Solar PV Park report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain sections of...
-
Product Insights
Interstitial Lung Fibrosis – Drugs In Development, 2023
Global Markets Direct’s, ‘Interstitial Lung Fibrosis - Drugs In Development, 2023’, provides an overview of the Interstitial Lung Fibrosis pipeline landscape. The report provides comprehensive information on the therapeutics under development for Interstitial Lung Fibrosis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the...
-
Sector Analysis
Italy Forecourt Market Size and Forecast by Segment and Fuel Retailer Profiles to 2027
Italy Forecourt Market Report Overview The total forecourt sales in Italy was EUR63.38 billion in 2022 and the market is expected to record a CAGR of less than 1% during 2023-2027. Customer demand for convenience is driving the growth and evolution of forecourt products and service offerings. Non-fuel retail offerings are gaining prominence as well. Italy Forecourt Market Outlook 2022-2027 (EUR Billion) Buy the Full Report for Additional Insights on the Italy Forecourt Market Forecast Download a Free Sample Report...
-
Product Insights
Falconara Power Plant
Falconara Power Plant is a thermal project located in Marche, Italy. The project is owned and developed by api energia SpA. The project came online in 2001. Empower your strategies with our Falconara Power Plant report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain sections of the report may be removed...
-
Product Insights
Castelfranco
Castelfranco is an Onshore Wind project located in Campania, Italy. The project is owned by Api-Anonima Petroli Italiana SpA (Inactive) and was developed by Filippo Sanseverino srl. The project came online in 1997. Empower your strategies with our Castelfranco report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain sections of the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Abiraterone Acetate in Metastatic Castration-Resistant Prostate Cancer (mCRPC)
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.Abiraterone Acetate in Metastatic Castration-Resistant Prostate Cancer (mCRPC) Drug Details:Abiraterone acetate (DRGT-45) is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Celecoxib in Post-Operative Pain
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.Celecoxib in Post-Operative Pain Drug Details:Celecoxib (MDC-CWM) is under development for the treatment of post operative...
-
Sector Analysis
Contract Pharmaceutical Dose Manufacturing Industry – Composition, Size, Market Share and Outlook, 2023 Edition
Contract Pharmaceutical Dose Manufacturing Industry Overview The total dose CMO contract revenue in 2022 represented significant growth over 2021 revenue. The growth rate was the highest recorded since 2011 for commercial contract dose manufacturing revenues, and surprisingly adds to the strong growth experienced in 2021, despite demand for COVID-19 vaccines and therapies waning in 2022. The Contract Pharmaceutical Dose Manufacturing Industry report is a comprehensive look at the finished dose contract manufacturing landscape in 2023. It includes an analysis of...